Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
Add more filters










Publication year range
1.
Cell Chem Biol ; 30(11): 1323, 2023 Nov 16.
Article in English | MEDLINE | ID: mdl-37977123
2.
PLoS One ; 18(3): e0282508, 2023.
Article in English | MEDLINE | ID: mdl-36897854

ABSTRACT

PKM2 is a rate-limiting enzyme in the glycolytic process and is involved in regulating tumor proliferation. Several amino acids (AAs) such as Asn, Asp, Val, and Cys have been shown to bind to the AA binding pocket of PKM2 and modulate its oligomeric state, substrate binding affinity, and activity. Although previous studies have attributed that the main chain and side chain of bound AAs are responsible for initiating signal to regulate PKM2, the signal transduction pathway remains elusive. To identify the residues involved in signal transfer process, N70 and N75 located at two ends of a ß strand connecting the active site and AA binding pocket were altered. Biochemical studies of these variants with various AA ligands (Asn, Asp, Val, and Cys), illustrate that N70 and N75, along with ß1 connecting these residues are part of the signal transduction pathway between the AA binding pocket and the active site. The results demonstrate that mutation of N70 to D prevents the transfer of the inhibitory signal mediated by Val and Cys, whereas N75 to L alteration blocks the activating signal initiated by Asn and Asp. Taken together, this study confirms that N70 is one of the residues responsible for transmitting the inhibitory signal and N75 is involved in the activation signal flow.


Subject(s)
Pyruvate Kinase , Amino Acids/metabolism , Catalytic Domain , Protein Isoforms/metabolism , Pyruvate Kinase/chemistry , Pyruvate Kinase/metabolism , Humans , Signal Transduction , Thyroid Hormone-Binding Proteins
4.
Cell Chem Biol ; 29(3): 351-352, 2022 03 17.
Article in English | MEDLINE | ID: mdl-35303438
11.
J Biol Chem ; 295(16): 5390-5403, 2020 04 17.
Article in English | MEDLINE | ID: mdl-32144209

ABSTRACT

Pyruvate kinase muscle isoform 2 (PKM2) is a key glycolytic enzyme involved in ATP generation and critical for cancer metabolism. PKM2 is expressed in many human cancers and is regulated by complex mechanisms that promote tumor growth and proliferation. Therefore, it is considered an attractive therapeutic target for modulating tumor metabolism. Various stimuli allosterically regulate PKM2 by cycling it between highly active and less active states. Several small molecules activate PKM2 by binding to its intersubunit interface. Serine and cysteine serve as an activator and inhibitor of PKM2, respectively, by binding to its amino acid (AA)-binding pocket, which therefore represents a potential druggable site. Despite binding similarly to PKM2, how cysteine and serine differentially regulate this enzyme remains elusive. Using kinetic analyses, fluorescence binding, X-ray crystallography, and gel filtration experiments with asparagine, aspartate, and valine as PKM2 ligands, we examined whether the differences in the side-chain polarity of these AAs trigger distinct allosteric responses in PKM2. We found that Asn (polar) and Asp (charged) activate PKM2 and that Val (hydrophobic) inhibits it. The results also indicate that both Asn and Asp can restore the activity of Val-inhibited PKM2. AA-bound crystal structures of PKM2 displayed distinctive interactions within the binding pocket, causing unique allosteric effects in the enzyme. These structure-function analyses of AA-mediated PKM2 regulation shed light on the chemical requirements in the development of mechanism-based small-molecule modulators targeting the AA-binding pocket of PKM2 and provide broader insights into the regulatory mechanisms of complex allosteric enzymes.


Subject(s)
Allosteric Site , Amino Acids/metabolism , Carrier Proteins/metabolism , Membrane Proteins/metabolism , Thyroid Hormones/metabolism , Allosteric Regulation , Amino Acids/chemistry , Carrier Proteins/antagonists & inhibitors , Carrier Proteins/chemistry , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Humans , Membrane Proteins/antagonists & inhibitors , Membrane Proteins/chemistry , Protein Binding , Protein Multimerization , Thyroid Hormones/chemistry , Thyroid Hormone-Binding Proteins
12.
J Biol Chem ; 295(51): 17425-17440, 2020 12 18.
Article in English | MEDLINE | ID: mdl-33453989

ABSTRACT

Pyruvate kinase muscle isoform 2 (PKM2) is a key glycolytic enzyme and transcriptional coactivator and is critical for tumor metabolism. In cancer cells, native tetrameric PKM2 is phosphorylated or acetylated, which initiates a switch to a dimeric/monomeric form that translocates into the nucleus, causing oncogene transcription. However, it is not known how these post-translational modifications (PTMs) disrupt the oligomeric state of PKM2. We explored this question via crystallographic and biophysical analyses of PKM2 mutants containing residues that mimic phosphorylation and acetylation. We find that the PTMs elicit major structural reorganization of the fructose 1,6-bisphosphate (FBP), an allosteric activator, binding site, impacting the interaction with FBP and causing a disruption in oligomerization. To gain insight into how these modifications might cause unique outcomes in cancer cells, we examined the impact of increasing the intracellular pH (pHi) from ∼7.1 (in normal cells) to ∼7.5 (in cancer cells). Biochemical studies of WT PKM2 (wtPKM2) and the two mimetic variants demonstrated that the activity decreases as the pH is increased from 7.0 to 8.0, and wtPKM2 is optimally active and amenable to FBP-mediated allosteric regulation at pHi 7.5. However, the PTM mimetics exist as a mixture of tetramer and dimer, indicating that physiologically dimeric fraction is important and might be necessary for the modified PKM2 to translocate into the nucleus. Thus, our findings provide insight into how PTMs and pH regulate PKM2 and offer a broader understanding of its intricate allosteric regulation mechanism by phosphorylation or acetylation.


Subject(s)
Pyruvate Kinase/metabolism , Acetylation , Allosteric Regulation , Glycolysis , Humans , Hydrogen-Ion Concentration , Lysine/metabolism , Molecular Mimicry , Phosphorylation , Phosphoserine/metabolism , Protein Binding
13.
Biochemistry ; 58(35): 3669-3682, 2019 09 03.
Article in English | MEDLINE | ID: mdl-31386812

ABSTRACT

Cancer cells regulate key enzymes in the glycolytic pathway to control the glycolytic flux, which is necessary for their growth and proliferation. One of the enzymes is pyruvate kinase muscle isoform 2 (PKM2), which is allosterically regulated by various small molecules. Using detailed biochemical and kinetic studies, we demonstrate that cysteine inhibits wild-type (wt) PKM2 by shifting from an active tetramer to a mixture of a tetramer and a less active dimer/monomer equilibrium and that the inhibition is dependent on cysteine concentration. The cysteine-mediated PKM2 inhibition is reversed by fructose 1,6-bisphosphate, an allosteric activator of PKM2. Furthermore, kinetic studies using two dimeric PKM2 variants, S437Y PKM2 and G415R PKM2, show that the reversal is caused by the tetramerization of wtPKM2. The crystal structure of the wtPKM2-Cys complex was determined at 2.25 Å, which showed that cysteine is held to the amino acid binding site via its main chain groups, similar to that observed for phenylalanine, alanine, serine, and tryptophan. Notably, ligand binding studies using fluorescence and isothermal titration calorimetry show that the presence of phosphoenolpyruvate alters the binding affinities of amino acids for wtPKM2 and vice versa, thereby unravelling the existence of a functionally bidirectional coupling between the amino acid binding site and the active site of wtPKM2.


Subject(s)
Carrier Proteins/antagonists & inhibitors , Carrier Proteins/chemistry , Cysteine/pharmacology , Enzyme Inhibitors/pharmacology , Membrane Proteins/antagonists & inhibitors , Membrane Proteins/chemistry , Thyroid Hormones/chemistry , Amino Acid Substitution/genetics , Amino Acids/chemistry , Amino Acids/metabolism , Carrier Proteins/genetics , Carrier Proteins/metabolism , Catalysis , Catalytic Domain/genetics , Crystallography, X-Ray , Humans , Isoenzymes/antagonists & inhibitors , Isoenzymes/chemistry , Isoenzymes/genetics , Isoenzymes/metabolism , Ligands , Membrane Proteins/genetics , Membrane Proteins/metabolism , Models, Molecular , Mutant Proteins/antagonists & inhibitors , Mutant Proteins/chemistry , Mutant Proteins/metabolism , Phosphoenolpyruvate/chemistry , Phosphoenolpyruvate/metabolism , Protein Binding , Protein Conformation , Serine/genetics , Thyroid Hormones/genetics , Thyroid Hormones/metabolism , Tyrosine/genetics , Thyroid Hormone-Binding Proteins
14.
Methods Enzymol ; 605: 291-323, 2018.
Article in English | MEDLINE | ID: mdl-29909828

ABSTRACT

The organosulfur metabolite dimethylsulfoniopropionate (DMSP) and its enzymatic breakdown product dimethyl sulfide (DMS) have important implications in the global sulfur cycle and in marine microbial food webs. Enormous amounts of DMSP are produced in marine environments where microbial communities import and catabolize it via either the demethylation or the cleavage pathways. The enzymes that cleave DMSP are termed "DMSP lyases" and generate acrylate or hydroxypropionate, and ~107tons of DMS annually. An important environmental factor affecting DMS generation by the DMSP lyases is the availability of metal ions as these enzymes use various cofactors for catalysis. This chapter summarizes advances on bacterial DMSP catabolism, with an emphasis on various biochemical methods employed for the isolation and characterization of bacterial DMSP lyases. Strategies are presented for the purification of DMSP lyases expressed in bacterial cells. Specific conditions for the efficient isolation of apoproteins in Escherichia coli are detailed. DMSP cleavage is effectively inferred, utilizing the described HPLC-based acrylate detection assay. Finally, substrate and metal binding interactions are examined using fluorescence and UV-visible assays. Together, these methods are rapid and well suited for the biochemical and structural characterization of DMSP lyases and in the assessment of uncharacterized DMSP catabolic enzymes, and new metalloenzymes in general.


Subject(s)
Aquatic Organisms/metabolism , Bacteria/metabolism , Carbon-Sulfur Lyases/isolation & purification , Enzyme Assays/methods , Apoenzymes/genetics , Apoenzymes/isolation & purification , Apoenzymes/metabolism , Carbon-Sulfur Lyases/genetics , Carbon-Sulfur Lyases/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Sulfides/metabolism , Sulfonium Compounds/metabolism
15.
Biochemistry ; 56(50): 6517-6520, 2017 Dec 19.
Article in English | MEDLINE | ID: mdl-29182273

ABSTRACT

Pyruvate kinase muscle isoform 2 (PKM2) catalyzes the terminal step in glycolysis, transferring a phosphoryl group from phosphoenolpyruvate to ADP, to produce pyruvate and ATP. PKM2 activity is allosterically regulated by fructose 1,6-bisphosphate (FBP), an upstream glycolytic intermediate. FBP stabilizes the tetrameric form of the enzyme. In its absence, the PKM2 tetramers dissociate, yielding a dimer-monomer mixture having lower enzymatic activity. The S437Y variant of PKM2 is incapable of binding FBP. Consistent with that defect, we find that S437Y exists in a monomer-dimer equilibrium in solution, with a Kd of ∼20 µM. Interestingly, however, the protein crystallizes as a tetramer, providing insight into the structural basis for impaired FBP binding of S437Y.


Subject(s)
Carrier Proteins/chemistry , Carrier Proteins/metabolism , Membrane Proteins/chemistry , Membrane Proteins/metabolism , Thyroid Hormones/chemistry , Thyroid Hormones/metabolism , Carrier Proteins/genetics , Cell Proliferation , Fructosediphosphates/metabolism , Glycolysis , Membrane Proteins/genetics , Phosphorylation , Polymorphism, Single Nucleotide/genetics , Protein Isoforms/metabolism , Protein Multimerization , Pyruvate Kinase/metabolism , Structure-Activity Relationship , Thyroid Hormones/genetics , Thyroid Hormone-Binding Proteins
16.
Biochemistry ; 56(43): 5771-5785, 2017 10 31.
Article in English | MEDLINE | ID: mdl-28981257

ABSTRACT

Prolyl hydroxylation is a very common post-translational modification and plays many roles in eukaryotes such as collagen stabilization, hypoxia sensing, and controlling protein transcription and translation. There is a growing body of evidence that suggests that prokaryotes contain prolyl 4-hydroxylases (P4Hs) homologous to the hypoxia-inducible factor (HIF) prolyl hydroxylase domain (PHD) enzymes that act on elongation factor Tu (EFTu) and are likely involved in the regulation of bacterial translation. Recent biochemical and structural studies with a PHD from Pseudomonas putida (PPHD) determined that it forms a complex with EFTu and hydroxylates a prolyl residue of EFTu. Moreover, while animal, plant, and viral P4Hs act on peptidyl proline, most prokaryotic P4Hs have been known to target free l-proline; the exceptions include PPHD and a P4H from Bacillus anthracis (BaP4H) that modifies collagen-like proline-rich peptides. Here we use biophysical and mass spectrometric methods to demonstrate that BaP4H recognizes full-length BaEFTu and a BaEFTu 9-mer peptide for site-specific proline hydroxylation. Using size-exclusion chromatography coupled small-angle X-ray scattering (SEC-SAXS) and binding studies, we determined that BaP4H forms a 1:1 heterodimeric complex with BaEFTu. The SEC-SAXS studies reveal dissociation of BaP4H dimeric subunits upon interaction with BaEFTu. While BaP4H is unusual within bacteria in that it is structurally and functionally similar to the animal PHDs and collagen P4Hs, respectively, this work provides further evidence of its promiscuous substrate recognition. It is possible that the enzyme might have evolved to hydroxylate a universally conserved protein in prokaryotes, similar to the PHDs, and implies a functional role in B. anthracis.


Subject(s)
Bacillus anthracis/metabolism , Bacterial Proteins/metabolism , Peptide Elongation Factor Tu/metabolism , Prolyl Hydroxylases/metabolism , Bacillus anthracis/chemistry , Bacillus anthracis/genetics , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Peptide Elongation Factor Tu/chemistry , Peptide Elongation Factor Tu/genetics , Prolyl Hydroxylases/chemistry , Prolyl Hydroxylases/genetics , Protein Binding , Protein Domains , X-Ray Diffraction
17.
Adv Protein Chem Struct Biol ; 109: 195-222, 2017.
Article in English | MEDLINE | ID: mdl-28683918

ABSTRACT

The biochemistry of dimethylsulfoniopropionate (DMSP) catabolism is reviewed. The microbes that catalyze the reactions central to DMSP catabolic pathways are described, and the focus is on the enzymology of the process. Approximately 109tons of DMSP is released annually by marine eukaryotes as an osmolyte. A vast majority of DMSP is assimilated by bacteria through either a demethylation or lyase pathways, producing either the methane thiol or the volatile dimethylsulfide (DMS), respectively. Enzymatic breakdown of DMSP generates ~107tons of DMS annually, which may have impact on global climate. DMS also acts as a chemoattractant for zooplanktons and seabirds. Both DMSP and DMS play a key role in the global sulfur cycle and are key nutrients for marine microbial growth. Important enzymes in the biochemical pathways of DMSP catabolism are covered in this review, with a focus on the latest developments in their mechanism.


Subject(s)
Bacteria/enzymology , Bacteria/metabolism , Bacterial Proteins/metabolism , Sulfonium Compounds/metabolism , Amino Acid Sequence , Bacteria/chemistry , Bacteria/genetics , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Coenzyme A-Transferases/chemistry , Coenzyme A-Transferases/genetics , Coenzyme A-Transferases/metabolism , Gene Expression Regulation, Bacterial , Lyases/chemistry , Lyases/genetics , Lyases/metabolism , Metabolic Networks and Pathways , Models, Molecular , Protein Conformation , Proteobacteria/chemistry , Proteobacteria/enzymology , Proteobacteria/genetics , Proteobacteria/metabolism , Sulfonium Compounds/chemistry
18.
Biochemistry ; 56(23): 2873-2885, 2017 06 13.
Article in English | MEDLINE | ID: mdl-28511016

ABSTRACT

Enormous amounts of the organic osmolyte dimethylsulfoniopropionate (DMSP) are produced in marine environments where bacterial DMSP lyases cleave it, yielding acrylate and the climate-active gas dimethyl sulfide (DMS). SAR11 bacteria are the most abundant clade of heterotrophic bacteria in the oceans and play a key role in DMSP catabolism. An important environmental factor affecting DMS generation via DMSP lyases is the availability of metal ions because they are essential cofactors for many of these enzymes. Here we examine the structure and activity of DddK in the presence of various metal ions. We have established that DddK containing a double-stranded ß-helical motif utilizes various divalent metal ions as cofactors for catalytic activity. However, nickel, an abundant metal ion in marine environments, adopts a distorted octahedral coordination environment and conferred the highest DMSP lyase activity. Crystal structures of cofactor-bound DddK reveal key metal ion binding and catalytic residues and provide the first rationalization for varying activities with different metal ions. The structures of DddK along with site-directed mutagenesis and ultraviolet-visible studies are consistent with Tyr 64 acting as a base to initiate the ß-elimination reaction of DMSP. Our biochemical and structural studies provide a detailed understanding of DMS generation by one of the ocean's most prolific bacteria.


Subject(s)
Alphaproteobacteria/enzymology , Aquatic Organisms/enzymology , Bacterial Proteins/metabolism , Carbon-Sulfur Lyases/metabolism , Models, Molecular , Sulfonium Compounds/metabolism , Acrylates/metabolism , Alphaproteobacteria/growth & development , Amino Acid Sequence , Aquatic Organisms/growth & development , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Binding Sites , Carbon-Sulfur Lyases/chemistry , Carbon-Sulfur Lyases/genetics , Catalytic Domain , Conserved Sequence , Crystallography, X-Ray , Mutagenesis, Site-Directed , Mutation , Nickel/chemistry , Oceans and Seas , Protein Conformation , Protein Conformation, beta-Strand , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/metabolism , Sequence Alignment , Sulfides/metabolism , Sulfonium Compounds/chemistry , Tyrosine/chemistry
19.
Biochemistry ; 55(44): 6162-6174, 2016 Nov 08.
Article in English | MEDLINE | ID: mdl-27755868

ABSTRACT

The marine microbial catabolism of dimethylsulfoniopropionate (DMSP) by the lyase pathway liberates ∼300 million tons of dimethyl sulfide (DMS) per year, which plays a major role in the biogeochemical cycling of sulfur. Recent biochemical and structural studies of some DMSP lyases, including DddQ, reveal the importance of divalent transition metal ions in assisting DMSP cleavage. While DddQ is believed to be zinc-dependent primarily on the basis of structural studies, excess zinc inhibits the enzyme. We examine the importance of iron in regulating the DMSP ß-elimination reaction catalyzed by DddQ as our as-isolated purple-colored enzyme possesses ∼0.5 Fe/subunit. The UV-visible spectrum exhibited a feature at 550 nm, consistent with a tyrosinate-Fe(III) ligand-to-metal charge transfer transition. Incubation of as-isolated DddQ with added iron increases the intensity of the 550 nm peak, whereas addition of dithionite causes a bleaching as Fe(III) is reduced. Both the Fe(III) oxidized and Fe(II) reduced species are active, with similar kcat values and 2-fold differences in their Km values for DMSP. The slow turnover of Fe(III)-bound DddQ allowed us to capture a substrate-bound form of the enzyme. Our DMSP-Fe(III)-DddQ structure reveals conformational changes associated with substrate binding and shows that DMSP is positioned optimally to bind iron and is in the proximity of Tyr 120 that acts as a Lewis base to initiate catalysis. The structures of Tris-, DMSP-, and acrylate-bound forms of Fe(III)-DddQ reported here illustrate various states of the enzyme along the reaction pathway. These results provide new insights into DMSP lyase catalysis and have broader significance for understanding the mechanism of oceanic DMS production.


Subject(s)
Carbon-Sulfur Lyases/chemistry , Metals/chemistry , Ferric Compounds/chemistry , Kinetics , Protein Conformation , Spectrophotometry, Ultraviolet , Substrate Specificity
20.
Acta Crystallogr D Struct Biol ; 72(Pt 5): 675-81, 2016 05.
Article in English | MEDLINE | ID: mdl-27139630

ABSTRACT

The prolyl 4-hydroxylases (P4Hs) are mononuclear nonheme iron enzymes that catalyze the formation of 4R-hydroxyproline from many different substrates, with various biological implications. P4H is a key player in collagen accumulation, which has implications in fibrotic disorders. The stabilization of collagen triple-helical structure via prolyl hydroxylation is the rate-limiting step in collagen biosynthesis, and therefore P4H has been extensively investigated as a potential therapeutic target of fibrotic disease. Understanding how these enzymes recognize cofactors and substrates is important and will aid in the future design of inhibitors of P4H. In this article, X-ray crystal structures of a metallocofactor- and α-ketoglutarate (αKG)-bound form of P4H from Bacillus anthracis (BaP4H) are reported. Structures of BaP4H were solved at 1.63 and 2.35 Šresolution and contained a cadmium ion and αKG bound in the active site. The αKG-Cd-BaP4H ternary complex reveals conformational changes of conserved residues upon the binding of metal ion and αKG, resulting in a closed active-site configuration required for dioxygen, substrate binding and catalysis.


Subject(s)
Anthrax/microbiology , Bacillus anthracis/chemistry , Bacillus anthracis/enzymology , Prolyl Hydroxylases/chemistry , Prolyl Hydroxylases/metabolism , Bacillus anthracis/metabolism , Catalytic Domain , Coenzymes/metabolism , Crystallography, X-Ray , Humans , Ketoglutaric Acids/metabolism , Models, Molecular , Protein Binding , Substrate Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...